Find a Doctor or Practice Location

Are you a referring physician?
I am searching for a
Reset Form
Adam Bagg, MD

Adam Bagg, MD Physician

Director, Hematology Director, Minimal Residual Disease Resource Laboratory Medical Director, Cytogenetics Laboratory Professor of Pathology and Laboratory Medicine at the Hospital of the University of Pennsylvania

Dr. Bagg is employed by Penn Medicine.

No Patient Satisfaction Reviews
Why not?

There is no publicly available rating for this medical professional for one of the following reasons:

  1. He or she is not employed by Penn Medicine.
  2. He or she does not see patients.
  3. He or she sees patients but has not yet received the minimum 30 patient satisfaction reviews in the past 12 months, ensuring that the rating is statistically reliable and a true reflection of patient satisfaction.

About Dr. Adam Bagg

Recognized annually in Philadelphia  magazine's Top Docs issue from 2010 - 2017

Recognized by America's Top Doctors, 2010, 2012-14

Clinical Specialties


  • Pathology and Laboratory Medicine

Programs & Centers:

Board Certification:

  • Pathology - Clinical Pathology, 1992
  • Pathology - Hematology, 1999

Clinical Expertise:

  • Blood Cancer
  • Bone Marrow Diseases
  • Bone Marrow Transplant
  • Cancer Screening and Diagnostics

Description of Clinical Expertise

Laboratory Hematology; Laboratory Evaluation of Hematologic Diseases; Leukemias; Lymphomas; Myelodysplastic Syndromes; Molecular Pathology; Myeloma; Hodgkin lymphoma

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Cigna
  • Cigna HealthSpring
  • CVS Health
  • Devon Health Services (Americare)
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Keystone First Medicare
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan

Education and Training

Medical School: University of the Witwatersrand School
Residency: Johannesburg General Hospital/Witwatersrand University
Residency: University of Witwatersrand and South
Residency: Georgetown University Medical Center
Fellowship: Georgetown University Medical Center


American Association for Cancer Research , National American Society of Hematology, National Association for Molecular Pathology, National Hematopathology Service, Boca Raton Regional Hospital, Boca Raton, FL, National Society of Hematopathology, National United States and Canadian Academy of Pathology, International United States and Canadian Academy of Pathology, National

Hospital Affiliation

Dr. Bagg is employed by Penn Medicine.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.


Description of Research Expertise:

Molecular genetics and pathology of Leukemias and Lymphomas; Myelodysplastic syndromes; Minimal residual disease; Hodgkin lymphoma

Selected Publications:

Wang SA, Hasserjian RP, Tam W, Tsai AG, Geyer JT, George TI, Foucar K, Rogers HJ, Hsi ED, Rea BA, Bagg A, Bueso-Ramos C, Arber DA, Verstovsek S, Orazi A: Bone marrow morphology is a strong discriminator between chronic eosinophilic leukemia, not otherwise specified from reactive idiopathic hypereosinophilic syndrome. Haematologica : 2017.

Geyer JT, Tam W, Liu YC, Chen Z, Wang SA, Bueso-Ramos C, Oak J, Arber DA, Hsi E, Rogers HJ, Levinson K, Bagg A, Hassane DC, Hasserjian RP, Orazi A: Oligomonocytic chronic myelomonocytic leukemia (chronic myelomonocytic leukemia without absolute monocytosis) displays a similar clinicopathologic and mutational profile to classical chronic myelomonocytic leukemia. Mod Pathol : 2017.

Xu Y, Wertheim G, Morrissette JJ, Bagg A: BRAF kinase domain mutations in de novo acute myeloid leukemia with monocytic differentiation. Leukemia Lymphoma 58 (3): 743-745,2017.

Fajgenbaum DC, Uldrick TS, Bagg A, Frank D, Wu D, Srkalovic G, Simpson D, Liu AY, Menke D, Chandrakasan S, Lechowicz MJ, Wong RS, Pierson S, Paessler M, Rossi JF, Ide M, Ruth J, Croglio M, Suarez A, Krymskaya V, Chadburn A, Colleoni G, Nasta S, Jayanthan R, Nabel CS, Casper C, Dispenzieri A, Fosså A, Kelleher D, Kurzrock R, Voorhees P, Dogan A, Yoshizaki K, van Rhee F, Oksenhendler E, Jaffe ES, Elenitoba-Johnson KS, Lim MS: International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease. Blood 129 : 1646-1657,2017.

Caponetti G, Bagg A: Demystifying the Diagnosis and Classification of Lymphoma: A Hematologist/Oncologist's Guide to the Hematopathologist's Galaxy. Journal of Community and Supportive Oncology 15 : 43-48,2017.

Wertheim GBW, Bagg A: NPM1 for MRD? Droplet Like It’s Hot. Journal of Molecular Diagnosis 19 : 498-501,2017.

Levinson KB, Bagg A: Atypical Chronic Myeloid Leukemia in Precision Molecular Pathology of Myeloid Neoplasms Springer : 2017.

Rogers HJ, Hsi ED, Tang G, Wang SA, Bueso-Ramos CE, Lubin D, Morrissette JJ, Bagg A, Cherukuri DP, George TI, Peterson L, Liu YC, Mathew S, Orazi A, Hasserjian RP: Most Myeloid Neoplasms with Deletion of Chromosome 16q are distinct from Acute Myeloid Leukemia with inv(16)(p13.1q22): A Bone Marrow Pathology Group Multicenter Study. Am J Clin Pathol 147 : 411-419,2017.

Wang Sa A, Tam Wayne, Tsai Albert G, Arber Daniel A, Hasserjian Robert P, Geyer Julia T, George Tracy I, Czuchlewski David R, Foucar Kathryn, Rogers Heesun J, Hsi Eric D, Bryan Rea B, Bagg Adam, Dal Cin Paola, Zhao Chong, Kelley Todd W, Verstovsek Srdan, Bueso-Ramos Carlos, Orazi Attilio: Targeted next-generation sequencing identifies a subset of idiopathic hypereosinophilic syndrome with features similar to chronic eosinophilic leukemia, not otherwise specified. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc : 2016.

Bhoj Vijay G, Arhontoulis Dimitrios, Wertheim Gerald, Capobianchi James, Callahan Colleen A, Ellebrecht Christoph T, Obstfeld Amrom E, Lacey Simon F, Melenhorst Jan J, Nazimuddin Farzana, Hwang Wei-Ting, Maude Shannon L, Wasik Mariusz A, Bagg Adam, Schuster Stephen, Feldman Michael D, Porter David L, Grupp Stephen A, June Carl H, Milone Michael C: Persistence of long-lived plasma cells and humoral immunity in individuals responding to CD19-directed CAR T cell therapy. Blood : 2016.

Academic Contact Info

Department of Pathology and Laboratory Medicine
Hospital of the University of Pennsylvania
7.103 Founders Pavilion
3400 Spruce Street

Philadelphia, PA 19104-4283
Phone: (215) 662-4280
Patient appointments: 800-789-7366 (PENN)

Related Links